NEDD4 and prostate cancer: Several preclinical studies revealed that NEDD4 has cancer chemopreventive and therapeutic capabilities against various malignancies, which include solid tumors such as brain, breast, colon, bladder, liver, pancreas, prostate cancers, etc., and hematological cancers such as lymphoma and leukemia.